NOVAVAX INC
Biological Products, (No Diagnostic Substances) · 21 FIRSTFIELD RD, GAITHERSBURG, MD
官方登记数据
0位关注者
1987成立于
关于 NOVAVAX INC
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部21 FIRSTFIELD RD, GAITHERSBURG, MD
成立1987
法律形式C Corporation
状态营业中
专利18 项专利
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITYJP2025128159A · 2025
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITYJP2024038170A · 2024
关键数据
法律信息
| 法定名称 | NOVAVAX INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1000694在 SEC EDGAR 上查看 ↗ |
| EIN | 22-2816046 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 21 FIRSTFIELD RD, GAITHERSBURG, MD |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026